SCHEMBL856620

SCHEMBL856620

CC(N)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17525149 1.00
SCHEMBL14498531 1.00
Hydrochloric Acid SCHEMBL57001 0.94
SCHEMBL23863495 0.78
SCHEMBL20086324 0.78
SCHEMBL21942581 0.78
SCHEMBL25388208 0.78
SCHEMBL6224317 0.78
SCHEMBL8474751 0.78
SCHEMBL31678595 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114014784-A Novel chiral or achiral monofluoroethylamine compounds, preparation method and application 许昌学院 2022-02-08 CN claimed
CN-113421971-A Method for preparing perovskite solar cell without charge transport layer through solvent pre-assistance 大连理工大学 2021-09-21 CN claimed
US-20210148893-A1 METHOD FOR DETERMINING IN VITRO BIOEQUIVALENCE OF A SUCRALFATE SUSPENSION SAMPLE TO A SUCRALFATE SUSPENSION REFERENCE LISTED DRUG (RLD) CLAYTON PHARMACEUTICALS LLC (US) 2021-05-20 US claimed
EP-3423829-A1 METHOD FOR DETERMININGIN VITRO Clayton Pharmaceuticals LLC (US) 2019-01-09 EP claimed
WO-2018204894-A1 METHOD FOR DETERMINING IN VITRO BIOEQUIVALENCE OF A SUCRALFATE SUSPENSION SAMPLE TO A SUCRALFATE SUSPENSION REFERENCE LISTED DRUG (RLD) CLAYTON PHARMACEUTICALS LLC (US) 2018-11-08 WO claimed
US-9919990-B2 Method for manufacturing methyl fluoride DAIKIN INDUSTRIES, LTD. (JP) 2018-03-20 US claimed
US-20160168060-A1 METHOD FOR MANUFACTURING METHYL FLUORIDE DAIKIN INDUSTRIES, LTD. (JP) 2016-06-16 US claimed
US-20090170131-A1 Agents for Imaging Apoptosis BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2009-07-02 US claimed
WO-2008038964-A1 GELDANAMYCIN DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREOF AND AGENT FOR THE PREVENTION AND TREATMENT OF TUMOR CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2008-04-03 WO claimed
WO-2007134127-A2 AGENTS FOR IMAGING APOPTOSIS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-11-22 WO claimed
US-6596868-B2 Reacting a cycloheptatriene derivative with a primary amine or ammonia in the presence of a base NIHON MEDI-PHYSICS CO., LTD. (JP) 2003-07-22 US claimed
US-20030109708-A1 Process for synthesizing anhydroecgonine derivative NIHON MEDI-PHYSICS CO., LTD. 2003-06-12 US claimed
US-20010020096-A1 Process for synthesizing anhydroecgonine derivative NIHON MEDI-PHYSICS CO., LTD. (JP) 2001-09-06 US claimed
EP-1127887-A1 Process for synthesizing anhydroecgonine derivative NIHON MEDI-PHYSICS Co., Ltd. (JP) 2001-08-29 EP claimed
JP-3077861-A None JP disclosed
US-20250215025-A1 FLUORINE ATOM CONTAINING SILANE COMPOUND DAIKIN INDUSTRIES, LTD. (JP) 2025-07-03 US disclosed
CN-120051477-A Silane compound containing fluorine atom 大金工业株式会社 2025-05-27 CN disclosed
WO-1996028090-A1 A METHOD OF MAGNETIC RESONANCE FOCUSED SURGICAL AND THERAPEUTIC ULTRASOUND IMARX PHARMACEUTICAL CORP. (US) 1996-09-19 WO disclosed
WO-1995024184-A1 GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS UNGER EVAN C (US) 1995-09-14 WO disclosed
JP-H0377861-A FLUORINE-CONTAINING SULFONAMIDE DERIVATIVE, INSECTICIDE AND ACARICIDE CENTRAL GLASS CO LTD 1991-04-03 JP disclosed